Ramsey Cheung

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. doi request reprint Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice?
    Ramsey C Cheung
    VA Palo Alto Healthcare System, Palo Alto, CA 94304, USA
    J Clin Gastroenterol 42:827-34. 2008
  2. ncbi request reprint Viral hepatitis and other infectious diseases in a homeless population
    Ramsey C Cheung
    Division of Gastroenterology and Hepatology, VA Palo Alto Health Care System, Palo Alto, California 94304, USA
    J Clin Gastroenterol 34:476-80. 2002
  3. doi request reprint Utilization and antiviral therapy in patients with chronic hepatitis C: analysis of ambulatory care visits in the US
    Ramsey Cheung
    Division of Gastroenterology and Hepatology, Stanford University, Stanford, CA, USA
    Dig Dis Sci 55:1744-51. 2010
  4. ncbi request reprint The impact of hepatitis C status on postoperative outcome
    Ramsey C Cheung
    Division of Gastroenterology and Hepatology, Cooperative Studies Program Coordinating Center, Department of Anesthesia, VA Palo Alto Health Care System Stanford University, California 94304, USA
    Anesth Analg 97:550-4, table of contents. 2003
  5. ncbi request reprint Effectiveness of a screening program for hepatitis C
    Ramsey C Cheung
    Division of Gastroenterology and Hepatology, VA Palo Alto Health Care System 154C, 3801 Miranda Ave, Palo Alto, California 94304, USA
    Dig Dis Sci 51:976-81. 2006
  6. ncbi request reprint Positive CAGE screen correlates with cirrhosis in veterans with chronic hepatitis C
    Ahmad Kamal
    Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California 94305, USA
    Dig Dis Sci 52:2564-9. 2007
  7. doi request reprint Assessment and utilization of rapid virologic response in US veterans with chronic hepatitis C: evaluating provider adherence to practice guidelines
    Elizabeth W Hwang
    Population Health Program Office of Public Health, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA 94304, USA
    J Clin Gastroenterol 47:264-70. 2013
  8. doi request reprint Changes in depressive symptoms and impact on treatment course among hepatitis C patients undergoing interferon-α and ribavirin therapy: a prospective evaluation
    Judith Chapman
    Veterans Affairs Palo Alto Health Care System, Psychology Service, Palo Alto, California, USA
    Am J Gastroenterol 106:2123-32. 2011
  9. ncbi request reprint Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race
    Xiao Song He
    Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA
    Hepatology 44:352-9. 2006
  10. ncbi request reprint Phenotypic and functional status of intrahepatic T cells in chronic hepatitis C
    Jinhui Wang
    Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA
    J Infect Dis 194:1068-77. 2006

Collaborators

Detail Information

Publications26

  1. doi request reprint Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice?
    Ramsey C Cheung
    VA Palo Alto Healthcare System, Palo Alto, CA 94304, USA
    J Clin Gastroenterol 42:827-34. 2008
    ..To determine the validity of fibrosis indexes based on simple laboratory tests in daily practice...
  2. ncbi request reprint Viral hepatitis and other infectious diseases in a homeless population
    Ramsey C Cheung
    Division of Gastroenterology and Hepatology, VA Palo Alto Health Care System, Palo Alto, California 94304, USA
    J Clin Gastroenterol 34:476-80. 2002
    ..To determine the prevalence of four common infectious diseases-hepatitis B, hepatitis C, human immunodeficiency virus (HIV), and tuberculosis-as well as co-infection rates and risk factors in a homeless population...
  3. doi request reprint Utilization and antiviral therapy in patients with chronic hepatitis C: analysis of ambulatory care visits in the US
    Ramsey Cheung
    Division of Gastroenterology and Hepatology, Stanford University, Stanford, CA, USA
    Dig Dis Sci 55:1744-51. 2010
    ..Studies on mostly veterans found the majority of chronic hepatitis C (CHC) patients were not treated. Little information exists on a broad-based population...
  4. ncbi request reprint The impact of hepatitis C status on postoperative outcome
    Ramsey C Cheung
    Division of Gastroenterology and Hepatology, Cooperative Studies Program Coordinating Center, Department of Anesthesia, VA Palo Alto Health Care System Stanford University, California 94304, USA
    Anesth Analg 97:550-4, table of contents. 2003
    ..90-1.30), which was not statistically significant (P = 0.405). In conclusion, we were unable to show HCV antibody status to be an independent risk factor for postoperative complications when other co-factors were considered...
  5. ncbi request reprint Effectiveness of a screening program for hepatitis C
    Ramsey C Cheung
    Division of Gastroenterology and Hepatology, VA Palo Alto Health Care System 154C, 3801 Miranda Ave, Palo Alto, California 94304, USA
    Dig Dis Sci 51:976-81. 2006
    ..Over the following 2 years, some were lost to follow-up, many continued to have contraindication(s) to antiviral therapy, and relatively few were treatment candidates...
  6. ncbi request reprint Positive CAGE screen correlates with cirrhosis in veterans with chronic hepatitis C
    Ahmad Kamal
    Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California 94305, USA
    Dig Dis Sci 52:2564-9. 2007
    ..6-431) and positive CAGE score (OR = 8.09; 95% CI, 1.15-57.1) were independent predictors of cirrhosis. These findings suggest that the CAGE questionnaire predicts advanced liver disease better than daily or lifetime drinking measures...
  7. doi request reprint Assessment and utilization of rapid virologic response in US veterans with chronic hepatitis C: evaluating provider adherence to practice guidelines
    Elizabeth W Hwang
    Population Health Program Office of Public Health, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA 94304, USA
    J Clin Gastroenterol 47:264-70. 2013
    ..As representative of overall provider adherence to practice guidelines, provider adherence to specific recommendations regarding rapid virologic response (RVR) was assessed...
  8. doi request reprint Changes in depressive symptoms and impact on treatment course among hepatitis C patients undergoing interferon-α and ribavirin therapy: a prospective evaluation
    Judith Chapman
    Veterans Affairs Palo Alto Health Care System, Psychology Service, Palo Alto, California, USA
    Am J Gastroenterol 106:2123-32. 2011
    ....
  9. ncbi request reprint Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race
    Xiao Song He
    Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA
    Hepatology 44:352-9. 2006
    ....
  10. ncbi request reprint Phenotypic and functional status of intrahepatic T cells in chronic hepatitis C
    Jinhui Wang
    Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA
    J Infect Dis 194:1068-77. 2006
    ..The distinct characteristics of intrahepatic T cells suggest that they play an important role in the immunopathogenesis of chronic hepatitis C...
  11. doi request reprint Tenofovir monotherapy and tenofovir plus entecavir combination as rescue therapy for entecavir partial responders
    Benjamin Yip
    Division of Gastroenterology and Hepatology, Stanford University Medical Center, 750 Welch Road, Suite 210, Palo Alto, CA, 94304, USA
    Dig Dis Sci 57:3011-6. 2012
    ..Our goal was to examine the complete viral suppression rate (undetectable HBV DNA PCR levels) with alternative therapies in such patients...
  12. doi request reprint Hepatitis C performance measure on hepatitis A and B vaccination: missed opportunities?
    Bridget Hernandez
    Pharmacy Service, VA Palo Alto Health Care System, Palo Alto, California 94304, USA
    Am J Gastroenterol 104:1961-7. 2009
    ..This study was conducted to determine adherence to the recently adopted physician performance measure on HAV and HBV vaccination...
  13. ncbi request reprint Interferon alfa regulated gene expression in patients initiating interferon treatment for chronic hepatitis C
    Xuhuai Ji
    Department of Medicine, Stanford University School of Medicine, Stanford, Palo Alto, CA 94304, USA
    Hepatology 37:610-21. 2003
    ..In conclusion, IFN-alpha-inducible genes can be identified in human PBMCs in vivo as well as ex vivo. Signature changes associated with different treatment outcomes may be found among these genes...
  14. ncbi request reprint The impact of chronic hepatitis C and comorbid psychiatric illnesses on health-related quality of life
    Joseph K Lim
    Division of Gastroenterology and Hepatology, Department of Internal Medicine, VA Palo Alto Health Care System, Palo Alto, California 94304, USA
    J Clin Gastroenterol 40:528-34. 2006
    ..To determine the relative impact of chronic hepatitis C (CHC) and comorbid psychiatric illness on the health-related quality of life (HRQoL)...
  15. ncbi request reprint Depression, anxiety, post-traumatic stress, and alcohol-related problems among veterans with chronic hepatitis C
    Cassandra L Lehman
    Division of Gastroenterology and Hepatology, Veterans Affairs Palo Alto Health Care System, California 94304, USA
    Am J Gastroenterol 97:2640-6. 2002
    ..The aim of this study was to determine the incidence of psychiatric comorbidities among veterans with chronic hepatitis C...
  16. ncbi request reprint A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C
    Hongjin Huang
    Celera Diagnostics, Alameda, CA 94502, USA
    Hepatology 46:297-306. 2007
    ..Conclusion: CRS is a better predictor than clinical factors in differentiating high-risk versus low-risk for cirrhosis in Caucasian CHC patients. Prospective studies should be conducted to further validate these findings...
  17. ncbi request reprint Clinical implications of hepatic steatosis in patients with chronic hepatitis C: a multicenter study of U.S. veterans
    Ke Qin Hu
    Loma Linda VA Medical Center, Loma Linda, CA, USA
    Dig Dis Sci 52:570-8. 2007
    ..We found that steatosis is independently associated with stage III-IV fibrosis. However, only HCV genotype, and not steatosis, obesity, or stage III-IV fibrosis, was associated with SVR to interferon alpha-2b and ribavirin treatment...
  18. ncbi request reprint Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C
    Hongjin Huang
    Celera Diagnostics, Alameda, California, USA
    Gastroenterology 130:1679-87. 2006
    ..The aim of this study was to identify genetic polymorphisms that can predict the risk of advanced fibrosis in patients with CHC...
  19. ncbi request reprint Incidence of statin hepatotoxicity in patients with hepatitis C
    Shirin Khorashadi
    Pharmacy Service, VA Palo Alto Health Care System, Palo Alto, California 94304, USA
    Clin Gastroenterol Hepatol 4:902-7; quiz 806. 2006
    ..Statins are considered contraindicated in patients with chronic liver disease. Our objective was to determine the risk of developing hepatotoxicity from statin therapy in hyperlipidemic patients with hepatitis C...
  20. ncbi request reprint Chronic hepatitis C in Latinos: natural history, treatment eligibility, acceptance, and outcomes
    Ramsey C Cheung
    VA Palo Alto Healthcare System and Stanford University School of Medicine, Palo Alto, California 94304, USA
    Am J Gastroenterol 100:2186-93. 2005
    ..The natural history of chronic hepatitis C and treatment response are different between blacks and Caucasians, but little comparable data is available about Latinos...
  21. ncbi request reprint Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C
    F Xavier López-Labrador
    Department of Medicine Gastroenterology and Hepatology Stanford University School of Medicine, Stanford, California, USA
    J Med Virol 72:575-85. 2004
    ..These data may be useful to improve T-cell assays using HCV NS3 peptides, taking into account the genetic diversity of this virus...
  22. ncbi request reprint The use of class-I HLA tetramers for the detection of hepatitis C virus NS3-specific CD8(+) T cells in patients with chronic infection
    F Xavier López-Labrador
    Department of Medicine Gastroenterology and Hepatology, Stanford University School of Medicine, CA 94305, USA
    J Immunol Methods 287:91-9. 2004
    ..New methods to detect virus-specific T-cell responses have recently been developed. Several human leukocyte antigen (HLA)-peptide tetramers for the detection of hepatitis C virus (HCV)-specific CD8(+) T cells are under evaluation...
  23. doi request reprint The impact of chronic hepatitis C and co-morbid illnesses on health-related quality of life
    Jeffrey W Kwan
    Division of Gastroenterology and Hepatology, Department of Medicine, VA Palo Alto Health Care System, 154C, 3801 Miranda Avenue, Palo Alto, CA 94304, USA
    Qual Life Res 17:715-24. 2008
    ....
  24. ncbi request reprint Hepatitis B vaccines
    Andy S Yu
    Liver Transplant Program, Stanford University Medical Center, 750 Welch Road, Suite 210, Stanford, CA 94305, USA
    Clin Liver Dis 8:283-300. 2004
    ..For those who remain nonresponders after the second series of vaccination, adjuvants such as GM-CSF may be considered, but their results are variable...
  25. ncbi request reprint A randomized, double-blind, placebo-controlled dose-escalation trial of merimepodib (VX-497) and interferon-alpha in previously untreated patients with chronic hepatitis C
    John G McHutchison
    Duke Clinical Research Institute and Division of Gastroenterology, Duke University Medical Center, Durham, NC, USA
    Antivir Ther 10:635-43. 2005
    ..Larger, longer duration trials incorporating pegylated IFN would be required to determine whether this combination, alone or with RBV, would increase either early or sustained virological response rates...
  26. ncbi request reprint High mortality rate in patients with advanced liver disease independent of exposure to general anesthesia
    Ramsey C Cheung
    Division of Gastroenterology and Hepatology, VA Palo Alto Health Care System, Palo Alto, CA 94304, USA
    J Clin Anesth 17:172-6. 2005
    ..To evaluate the survival of patients with advanced liver disease to determine if known exposure to general anesthesia within a 5-year period has a measurable effect on mortality...